Ultragenyx Pharmaceutical
Christine Broderick has extensive work experience in the field of clinical operations. Christine is currently serving as the Vice President of Clinical Operations at Ultragenyx since June 2023. Prior to this, they held various roles at GlaxoSmithKline, including Global Clinical Operations Asset Lead, Operations and Science Leader, Neuroscience Point of Contact, US Monitoring Manager, and Clinical Research Associate. Christine'stenure at GlaxoSmithKline lasted from December 2000 to June 2023.
Christine Broderick attended the University of Delaware from 1992 to 1996, where they earned a degree in Nutrition and Chemistry. Christine also obtained additional certifications in Influencing Others and Strategic Thinking from LinkedIn in 2020.
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.